These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10626736)

  • 1. Substitution of aspartic acid at beta57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (alpha1*0201, beta1*0302) and (alpha1*0201, beta1*0303).
    Sato AK; Sturniolo T; Sinigaglia F; Stern LJ
    Hum Immunol; 1999 Dec; 60(12):1227-36. PubMed ID: 10626736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
    Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
    Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus.
    Ettinger RA; Liu AW; Nepom GT; Kwok WW
    J Immunol; 2000 Sep; 165(6):3232-8. PubMed ID: 10975839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia.
    Delgado JC; Baena A; Thim S; Goldfeld AE
    J Immunol; 2006 Jan; 176(2):1090-7. PubMed ID: 16393997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential.
    Johansen BH; Jensen T; Thorpe CJ; Vartdal F; Thorsby E; Sollid LM
    Immunogenetics; 1996; 45(2):142-50. PubMed ID: 8952964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DQB1 codon 57 is critical for peptide binding and recognition.
    Kwok WW; Domeier ME; Johnson ML; Nepom GT; Koelle DM
    J Exp Med; 1996 Mar; 183(3):1253-8. PubMed ID: 8642268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity.
    Khalil-Daher I; Boisgérault F; Feugeas JP; Tieng V; Toubert A; Charron D
    Eur J Immunol; 1998 Nov; 28(11):3840-9. PubMed ID: 9842927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
    Nepom BS; Nepom GT; Coleman M; Kwok WW
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.
    Reizis B; Altmann DM; Cohen IR
    Eur J Immunol; 1997 Oct; 27(10):2478-83. PubMed ID: 9368599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific antibodies distinguish single amino acid substitutions in position 57 in HLA-DQ beta-chain alleles associated with insulin-dependent diabetes.
    Atar D; Dyrberg T; Michelsen B; Karlsen A; Kofod H; Mølvig J; Lernmark A
    J Immunol; 1989 Jul; 143(2):533-8. PubMed ID: 2738402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus.
    Rønningen KS; Iwe T; Halstensen TS; Spurkland A; Thorsby E
    Hum Immunol; 1989 Nov; 26(3):215-25. PubMed ID: 2606746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
    Kwok WW; Nepom GT; Raymond FC
    J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusive HLA-DQ factors do not explain susceptibility to insulin-dependent diabetes.
    Martinez-Laso J; Vicario JL; Corell A; Martin-Villa JM; Morales P; Lledó G; Arnaiz-Villena A
    Hum Immunol; 1991 Jun; 31(2):134-8. PubMed ID: 1676704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding of peptides substituted at putative C-terminal anchor residue to HLA-DQ8 and DQ9 differing only at beta 57.
    Oiso M; Nishi T; Ishikawa T; Nishimura Y; Matsushita S
    Hum Immunol; 1997 Jan; 52(1):47-53. PubMed ID: 9021409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex interplay of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for insulin-dependent diabetes mellitus.
    Tosi G; Brunelli S; Mantero G; Magalini AR; Soffiati M; Pinelli L; Tridente G; Accolla RS
    Mol Immunol; 1994 Apr; 31(6):429-37. PubMed ID: 8183282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
    van de Wal Y; Kooy YM; Drijfhout JW; Amons R; Papadopoulos GK; Koning F
    Immunogenetics; 1997; 46(6):484-92. PubMed ID: 9321428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule.
    van de Wal Y; Kooy YM; Drijfhout JW; Amons R; Koning F
    Immunogenetics; 1996; 44(4):246-53. PubMed ID: 8753854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes.
    Parry CS; Brooks BR
    Biol Direct; 2008 Oct; 3():42. PubMed ID: 18854049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak.
    Nelson CA; Viner NJ; Young SP; Petzold SJ; Unanue ER
    J Immunol; 1996 Jul; 157(2):755-62. PubMed ID: 8752926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus.
    Rønningen KS; Undlien DE; Ploski R; Maouni N; Konrad RJ; Jensen E; Hornes E; Reijonen H; Colonna M; Monos DS
    Eur J Immunol; 1993 May; 23(5):1050-6. PubMed ID: 8477801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.